Latest news
{{'2026-01-20T13:30:00Z' | dateFormatFilter}}
Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
{{'2026-01-05T13:00:00Z' | dateFormatFilter}}
Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
{{'2025-12-22T22:50:36Z' | dateFormatFilter}}
Novo Nordisk A/S: Wegovy® pill approved in the US as first oral GLP-1 for weight management
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
